Skip to main content
SpringerLink
Log in

Screening op diabetes: wie, hoe en waarom (niet)?

  • Nascholing
  • Published:
Tijdschrift voor praktijkondersteuning Aims and scope

Samenvatting

Ruim 1 miljoen Nederlanders hebben momenteel diabetes, voornamelijk type 2 (www.diabetesfonds.nl, 2015). Naar schatting 250.000 mensen daarvan hebben diabetes zonder het te weten. Dit komt omdat het jaren kan duren voordat mensen met diabetes type 2 klachten krijgen, zoals dorst en vaak plassen.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Notes

  1. Hindo(e)staan: afstammeling van naar Suriname geëmigreerde bewoners van het voormalige Brits-Indië

Literatuur

  1. Rutten GEHM, De Grauw WJC, Nijpels G, Houweling ST, Van de Laar FA, Bilo HJ, et al. NHG -Standaard Diabetes mellitus type 2 (derde herziening). www.nhg.org.

  2. Kahn R, Alperin P, Eddy D, Borch-Johnsen K, Buse J, Feigelman J, et al. Age at initiation and frequency of screening to detect type 2 diabetes: a cost-effectiveness analysis. Lancet 2010;375:1365–74.

    Article  PubMed  Google Scholar 

  3. American Diabetes Association. Standards of medical care in diabetes 2015: summary of revisions. Diabetes Care 2015;38 Suppl:S4.

    Article  Google Scholar 

  4. Klein Woolthuis EP, De Grauw WJ, Van Gerwen WH, Van den Hoogen HJ, Van de Lisdonk EH, Metsemakers JF, et al. Yield of opportunistic targeted screening for type 2 diabetes in primary care: the Diabscreen study. Ann Fam Med 2009;7:422–30.

    Article  PubMed  Google Scholar 

  5. Den Engelsen C, Van den Donk M, Gorter KJ, Salome PL, Bobbink IW, Rutten GEHM. Opsporing van het metabool syndroom door mensen zelf hun middelomtrek te laten meten. Ned Tijdschr Geneeskd 2010;154:A102–8.

    Google Scholar 

  6. Engelgau MM, Narayan KM, Herman WH. Screening for type 2 diabetes. Diabetes Care 2000;23:1563–80.

    Article  CAS  PubMed  Google Scholar 

  7. Janssen P, Gorter K, Stolk R, Rutten G. Low yield of populationbased screening for type 2 diabetes in the Netherlands: the ADDITIO N Netherlands study. Fam Pract 2007;24:555–61.

    Article  CAS  PubMed  Google Scholar 

  8. Khunti K, Davies M. Should we screen for type 2 diabetes: Yes. BMJ 2012;345:e451–4.

    Article  Google Scholar 

  9. Goyder E, Irwig L, Payne N. Should we screen for type 2 diabetes? No. BMJ 2012;345:e451–6.

    Article  Google Scholar 

  10. Simmons RK, Echouffo-Tcheugui JB, Sharp SJ, Sargeant LA, Williams KM, Prevost AT, et al. Screening for type 2 diabetes and population mortality over 10 years (ADDITIO N-Cambridge): a cluster-randomised controlled trial. Lancet 2012;380:1741–8.

    Article  PubMed Central  PubMed  Google Scholar 

  11. Klein Woolthuis EP, De Grauw WJ, Van Keeken SM, Akkermans RP, Van de Lisdonk EH, Metsemakers JF, et al. Vascular outcomes in patients with screen-detected or clinically diagnosed type 2 diabetes: Diabscreen study follow-up. Ann Fam Med 2013;11:20–7.

    Article  PubMed Central  PubMed  Google Scholar 

  12. Black JA, Sharp SJ, Wareham NJ, Sandbaek A, Rutten GE, Lauritzen T, et al. Does early intensive multifactorial therapy reduce modelled cardiovascular risk in individuals with screendetected diabetes? Results from the ADDITIO N-Europe cluster randomized trial. Diabet Med 2014;31:647–56.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  13. Griffin SJ, Borch-Johnsen K, Davies MJ, Khunti K, Rutten GE, Sandbaek A, et al. Effect of early intensive multifactorial therapy on 5-year cardiovascular outcomes in individuals with type 2 diabetes detected by screening (ADDITIO N-Europe): a clusterrandomised trial. Lancet 2011;378:156–67.

    Article  PubMed Central  PubMed  Google Scholar 

  14. Adriaanse MC, Snoek FJ. The psychological impact of screening for type 2 diabetes. Diabetes Metab Res Rev 2006;22:20–5.

    Article  PubMed  Google Scholar 

  15. Klein Woolthuis EP, De Grauw WJ, Cardol M, Van Weel C, Metsemakers JF, Biermans MC. Patients’ and partners’ illness perceptions in screen-detected versus clinically diagnosed type 2 diabetes: partners matter! Fam Pract 2013;30:418–25.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Huisartsenpraktijk Meekes & Klein Woolthuis, Doornlaan 1D, 67717, Ede, BN, The Netherlands

    Erwin Klein Woolthuis

Authors
  1. Erwin Klein Woolthuis
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Erwin Klein Woolthuis.

Additional information

Auteursgegevens

Huisartsenpraktijk Meekes & Klein Woolthuis, Doornlaan 1D, 6717 BN, Ede: dr. E.P. Klein Woolthuis, huisarts en kaderhuisarts diabetes.

Correspondentie: e.p.kleinwoolthuis@huisarts.com.

Mogelijke belangenverstrengeling: niets gemeld.

Reageren?

Jullie mening is belangrijk voor ons. Vragen of opmerkingen? Laat het ons weten via tpo@nhg.org of of via twitter @TPOnhg.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Klein Woolthuis, E. Screening op diabetes: wie, hoe en waarom (niet)?. TIJD. PRAKT.ONDERST. 10, 78–82 (2015). https://doi.org/10.1007/s12503-015-0042-7

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12503-015-0042-7

Search

Navigation